Immediate Impact
56 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Germana Tognon being referenced
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Germana Tognon | 724 | 320 | 259 | 584 | 36 | 1.2k | |
| Chad A. Hamilton | 488 | 287 | 209 | 487 | 26 | 996 | |
| Elisabetta Bandiera | 562 | 337 | 404 | 377 | 32 | 1.4k | |
| Darren Wheeler | 554 | 253 | 165 | 389 | 30 | 1.1k | |
| W. Michael Hogan | 512 | 376 | 254 | 359 | 33 | 1.3k | |
| A. Berchuck | 665 | 332 | 413 | 370 | 42 | 1.4k | |
| M. Baekelandt | 645 | 517 | 425 | 417 | 55 | 1.4k | |
| Mark Messing | 460 | 412 | 252 | 293 | 29 | 1.0k | |
| Gabriella Parma | 842 | 604 | 290 | 587 | 53 | 1.6k | |
| Michele De Nictolis | 474 | 320 | 329 | 340 | 52 | 1.3k | |
| Renata Tassi | 500 | 331 | 385 | 334 | 30 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...